142 related articles for article (PubMed ID: 33095915)
21. Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.
O'Brien MM; Cao X; Pounds S; Dahl GV; Raimondi SC; Lacayo NJ; Taub J; Chang M; Weinstein HJ; Ravindranath Y; Inaba H; Campana D; Pui CH; Rubnitz JE
Leukemia; 2013 Mar; 27(3):731-4. PubMed ID: 22918081
[No Abstract] [Full Text] [Related]
22. Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus.
Colović M; Janković G; Lazarević V; Novak A
Med Oncol; 1997 Mar; 14(1):31-4. PubMed ID: 9232608
[TBL] [Abstract][Full Text] [Related]
23. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
24. [Congenital transient leukemia: a case report].
Li-Thiao-Te V; Bourges-Petit E; Capiod JC; Horle B; Micheli J; Morin G; Maingourd Y; Pautard B
Arch Pediatr; 2008 Jan; 15(1):33-6. PubMed ID: 18162385
[TBL] [Abstract][Full Text] [Related]
25. [Phenotypic analysis of acute megakaryoblastic leukemia following myelodysplastic syndrome. Evidence for leukemic cells reacting with 3A1 (CD7) and A2B5 monoclonal antibodies].
Uike N; Kozuru M; Takeichi N; Shibata K; Akiyoshi T; Anami K; Shibuya T; Niho Y; Oku K; Takeshita M
Rinsho Ketsueki; 1988 Jun; 29(6):889-95. PubMed ID: 3166500
[No Abstract] [Full Text] [Related]
26. A case of acute megakaryocytic leukemia with hematogones.
Richard G; Brody J; Sun T
Leukemia; 1993 Nov; 7(11):1900-3. PubMed ID: 8231260
[TBL] [Abstract][Full Text] [Related]
27. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
Duchayne E; Fenneteau O; Pages MP; Sainty D; Arnoulet C; Dastugue N; Garand R; Flandrin G; ;
Leuk Lymphoma; 2003 Jan; 44(1):49-58. PubMed ID: 12691142
[TBL] [Abstract][Full Text] [Related]
28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
29. Eyelid mass as the presenting finding in a child with Down syndrome and acute megakaryoblastic leukemia.
Sandoval C; Davis A; Jayabose S
Pediatrics; 2005 Mar; 115(3):810-1. PubMed ID: 15741393
[TBL] [Abstract][Full Text] [Related]
30. Acute megakaryoblastic leukaemia in a child.
Russo F; Buda F; Buda C; Aragona P; Tessitori G; Simon G; Chillemi S; Caristi N; Faiella A
Eur J Cancer; 1991; 27(12):1713-4. PubMed ID: 1782091
[No Abstract] [Full Text] [Related]
31. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome.
Zipusky A
J Pediatr Hematol Oncol; 1996 Feb; 18(1):10-2. PubMed ID: 8556363
[No Abstract] [Full Text] [Related]
32. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM; Aguilera RP; Nieto S; Kofman S
Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
[TBL] [Abstract][Full Text] [Related]
33. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
34. Splenic rupture in acute megakaryoblastic leukemia.
Wong P; Takabayashi K; Sugiura Y; Asai T; Itoh K; Yoshida S; Horie H
Jpn J Med; 1987 May; 26(2):234-6. PubMed ID: 3476781
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous detection of platelet-associated antigen and platelet peroxidase on buffy coat cells from bone marrow in two patients with pediatric acute megakaryocytic leukemia.
Kinugawa N; Okimoto Y; Hata J
J Pediatr Hematol Oncol; 1999; 21(5):451-2. PubMed ID: 10524465
[No Abstract] [Full Text] [Related]
36. The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome.
Malkin D; Brown EJ; Zipursky A
Cancer Genet Cytogenet; 2000 Jan; 116(1):1-5. PubMed ID: 10616523
[TBL] [Abstract][Full Text] [Related]
37. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
Tchernia G; Lejeune F; Boccara JF; Denavit MF; Dommergues JP; Bernaudin F
J Pediatr Hematol Oncol; 1996 Feb; 18(1):59-62. PubMed ID: 8556372
[TBL] [Abstract][Full Text] [Related]
38. Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
[TBL] [Abstract][Full Text] [Related]
39. Osteolytic tumors in acute megakaryoblastic leukemia.
Dharmasena F; Wickham N; McHugh PJ; Catovsky D; Galton DA
Cancer; 1986 Nov; 58(10):2273-7. PubMed ID: 3463389
[TBL] [Abstract][Full Text] [Related]
40. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
